Clinical Trials
9 trialsNCT06820320 2026-03-06
Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT00661622 2025-05-16
Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
Thomas Jefferson University
Phase 2 Completed
NCT03472586 2025-04-24
Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver
Thomas Jefferson University
Phase 2 Completed
NCT01678664 2024-09-25
EVACEL
Federation Francophone de Cancerologie Digestive
Phase 2 Completed
NCT00003907 2023-07-05
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00335829 2021-08-13
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Yale University
Phase 2 Completed
NCT00839722 2019-06-20
EFU
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT03048123 2017-02-09
HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B
Sun Yat-sen University
Phase 2 Completed
NCT00028626 2013-06-05
Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed